LACROIX-DESMAZES; Sebastien

Patent Applications and Registrations

Patent applications and USPTO patent grants for LACROIX-DESMAZES; Sebastien.The latest application filed is for "methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with fc-coupled antigens".

Company Profile

1.4.12

LACROIX-DESMAZES; Sebastien - Paris FR
Lacroix-Desmazes; Sebastien - Issy-les-Moulineaux FR
Lacroix-Desmazes; Sebastien - Issy-Les0-Moulineaux FR
Lacroix-Desmazes; Sebastien - Ville D'Avray FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Pharmaceutical Compositions For Inducing Immune Tolerance By Mucosal Vaccination With Fc-coupled Antigens App 20220175896 - MALLONE; Roberto ; et al.	2022-06-09
Combination Of Her2/neu Antibody With Heme For Treating Cancer App 20220047701 - DIMITROV; Jordan ; et al.	2022-02-17
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins App 20210246469 - LACROIX-DESMAZES; Sebastien ; et al.	2021-08-12
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins App 20210228738 - LACROIX-DESMAZES; Sebastien ; et al.	2021-07-29
Methods And Pharmaceutical Compositions For Inducing Immune Tolerance By Mucosal Vaccination With Fc-coupled Antigens App 20200155658 - MALLONE; Roberto ; et al.	2020-05-21
Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens Grant 10,507,234 - Mallone , et al. Dec	2019-12-17
Methods And Pharmaceutical Compositions For Inducing Immune Tolerance By Mucosal Vaccination With Fc-coupled Antigens App 20180207250 - MALLONE; Roberto ; et al.	2018-07-26
Uses of Humanized Cobra Venom Factor for Reducing or Preventing Immunogenicity App 20170128544 - VOGEL; Carl-Wilhelm ; et al.	2017-05-11
Prenatal Therapy To Induce Immune Tolerance App 20170072032 - Mallone; Roberto ; et al.	2017-03-16
Method Of Treating Haemophilia By Inducing Tolerance To Blood Factors App 20160220644 - LACROIX-DESMAZES; SEBASTIEN ; et al.	2016-08-04
Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A Grant 8,802,620 - Chtourou , et al. August 12, 2	2014-08-12
Demannosylated Recombinant Factor Viii [[vii]] For The Treatment Of Patients With Haemophilia A App 20100197578 - Chtourou; Abdessatar Sami ; et al.	2010-08-05
Inhibition of the Anti-FVIII Immune Response App 20090317373 - Kaveri; Srini V. ; et al.	2009-12-24
Catalytic anti-factor VIII allo-antibodies App 20090208512 - Kaveri; Srinivas ; et al.	2009-08-20
Catalytic anti-factor VIII allo-antibodies Grant 7,507,540 - Kaveri , et al. March 24, 2	2009-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.